Jayvadan Vaishnav

Dr. Jayvadan Vaishnav

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Experimental Cell Research
Verified
Journal Article
Closed access
HMHina Mir
Hina Mir
JRJyotika Rajawat
Jyotika Rajawat
IVIqbal Vohra
Iqbal Vohra
JVJayvadan Vaishnav
Jayvadan Vaishnav
AKAshlesha Kadam
Ashlesha Kadam
RBRasheedunnisa Begum
Rasheedunnisa Begum

1 October 2021 in Protein Expression and Purification
Verified
Journal Article
Closed access
AKAshlesha Kadam
Ashlesha Kadam
SASyed Abuthakir
Syed Abuthakir
TJTina Jubin
Tina Jubin
JVJayvadan Vaishnav
Jayvadan Vaishnav
AGAbhishek Garg
Abhishek Garg
RBRasheedunnisa Begum
Rasheedunnisa Begum

7 August 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YCYashika Choudhary
Yashika Choudhary
BMBen Ali Moutughimou
Ben Ali Moutughimou
VUVijay Jagdish Upadhye
Vijay Jagdish Upadhye
SJShahnawaz D. Jadeja
Shahnawaz D. Jadeja
JVJayvadan Vaishnav
Jayvadan Vaishnav
Autoimmune diseases affect 5–10% of the global population, with a prevalence of 13% in women and 7% in men. Despite advances in immunology, the molecular basis of immune dysregulation remains limited. Nardilysin (NRD convertase, NRDc), a zinc-dependent metalloendopeptidase, has been identified as an enzyme involved in this dysregulation. Recent studies have identified NRDc dysregulation as a shared feature across type 1 diabetes (T1D), rheumatoid Arthritis (RA), and vitiligo, though the specific mechanism implicated differs by the disease involved. Reported roles for NRDc include modulating the release of the immune checkpoint protein VTCN1 (B7-H4), modulation of pro-inflammatory cytokines, and activation of ADAM17-mediated release of TNF-α and its receptors. While NRDc is recognized for its role in immune signaling, gene transcription, cell differentiation, proliferation, homeostasis, thermogenesis, and metabolism, a unified framework connecting NRDc’s multifaceted enzymatic activity to autoimmunity is currently lacking. We review current literature to construct such a framework, positioning it as hypothesis-generating by outlining specific, testable predictions to guide future investigation. Based on the literature, we propose that NRDc functions as a crucial molecular indicator and a therapeutic interface, rather than just a bystander enzyme.